NBCC (India) has secured a total business of Rs. 361.91 crore in the month of April 2019. Earlier, the company had secured a total business of Rs. 3,031.70 crore in March 2019.

Indoco Remedies announced that it received approval from the UK-MHRA (Medicines and Healthcare Products Regulatory Agency) for its new solid dosages manufacturing facility in Baddi, Himachal Pradesh (Baddi III unit). The inspection was held from October 16 to 18, 2018.

We have found some mid-cap stocks that outperformed and underperformed in the month of April as compared to the mid-cap index. Read on to find out more....

Gujarat-based pipes and tubes manufacturer, Ratnamani Metals & Tubes Limited informed in the exchange through a filing that the company has secured a new order for CS coated pipes.

Natco Pharma’s marketing partner Alvogen has received final approval of Abbreviated New Drug Application (ANDA) from USFDA for Nitroglycerin Sublingual Tablets USP, 0.3 mg, 0.4 mg, and 0.6 mg.

Following stocks are close to their 52-weeks low as at 12:51 p.m. on May 8, 2019.

The markets on May 8, 2019 opened gap down. BSE Sensex is trading at 37,999.34, down by 277.29 points and the Nifty is trading at 11,418.65, down by 79.25 points. 

Neogen Chemicals Limited has made a strong debut on BSE by getting listed with 16.7 per cent premium.

Trigyn Technologies Limited has informed the bourses that UNAIDS has signed a non-exclusive Long-Term Agreement (LTA) with its wholly-owned subsidiary Trigyn Technologies Inc. for providing open source IT services like Drupal/PHP and Django/Python.

Overall volumes in futures & options currently stand at 1.45 crore contracts with a turnover of Rs. 9,81,837.10 crore.